{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/01/3304397/0/en/Outlook-Therapeutics-Announces-Resubmission-of-Biologics-License-Application-to-U-S-FDA-for-ONS-5010-LYTENAVA-bevacizumab-vikg.html", "message": "News view counter 769893 successfully enlarged"}